UBS Group
PBH icon

UBS Group’s Prestige Consumer Healthcare PBH Stock Holding History

UBS Group’s Portfolio PBH Stock Details PBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,000
Closed -$56K – 7893
2017
Q1 		$56K Hold
1,000
– – ﹤0.01% 5438
2016
Q4 		$52K Sell
1,000
-1,000
-50% -$48.3K ﹤0.01% 5800
2016
Q3 		$97K Buy
+2,000
New +$101K ﹤0.01% 5013

Other funds holding PBH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's PBH Position: Q2 2026 in Review

UBS Group increased its Prestige Consumer Healthcare (PBH) stake by 63% in Q2 2026, buying an estimated $12.7M and bringing the position to 638,605 shares worth $30.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2258.

UBS Group first reported a position in PBH in Q4 2014 and has held it in 47 quarters since. The position peaked at $30.6M in Q2 2025. 320 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • UBS Group held 638,605 shares of Prestige Consumer Healthcare worth $30.2M as of Q2 2026.
  • UBS Group bought 246,396 Prestige Consumer Healthcare shares in Q2 2026, an estimated $12.7M.
  • Prestige Consumer Healthcare made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2258 holding.
  • UBS Group first reported a position in Prestige Consumer Healthcare in Q4 2014 and has held it in 47 quarters since.
  • UBS Group's Prestige Consumer Healthcare position peaked at $30.6M in Q2 2025.
  • 320 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.